On March 22-23, 2016, the US-Algeria Business Council, the PhRMA group, the Embassy of Algeria in Washington, DC, and the Ministry of Health of Algeria will convene the ALGERIA 2020 Leadership Committee Meeting in Algiers, Algeria, with executives from the international pharmaceutical sector. This meeting will be a follow-up strategy session to the signing of the ALGERIA 2020 Memorandum of Understanding between the National Drug Testing Laboratory and PhRMA at the 2014 BIO International Convention in San Diego. The ALGERIA 2020 Leadership Committee designated three working groups with specific avenues of activity to implement significant upgrades in the healthcare system in Algeria.

The three avenues are: Educational & Training Exchanges, Regulatory Harmonization and Drug Development & Manufacturing.

The PhRMA group will meet privately with the MOH on March 22, 2016 and a Conference for public and media is scheduled on March 23rd at the Hilton Hotel to highlight the road map of Algeria 2020 project.